Author

Jinnan Li

Observed name: Li, Jinnan

Institution: Lilly (China)

Observed institutions: University of California, Los Angeles, Lilly (China)

ORCID: 0000-0002-8393-3118

Observed ORCID: 0000-0002-8393-3118

OpenAlex ID: A5088537477

Indirect Comparison of Sintilimab and Other PD-L1 Inhibitors for First-Line Treatment of Non-Squamous Non-Small-Cell Lung Cancer

2022 · Lei Zhang, Yijiao Qian, et al. · Future Oncology · 11

Real-World Analysis of Clinical Characteristics, Treatment Patterns, and Patient-Reported Outcomes of Insufficient Responders and Responders to Prescribed Acute Migraine Treatment in China

2023 · Lei Zhang, Diego Novick, et al. · Pain and Therapy · 7

Results from NEXT-D: the association of a pre-diabetes-specific health plan and rates of incident diabetes among a national sample of working-age adults

2020 · Tannaz Moin, Jinnan Li, et al. · BMJ Open Diabetes Research & Care · 2

Works count: 4

Citation count: 20

H-index: 2

I10-index: 1